One world health: Socioeconomic burden and parasitic disease control priorities

Veterinary Parasitology

Volumn 195, Issue 3-4, 2013, Pages 223-232

  Torgerson, Paul R ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Cost effectiveness; Parasitic zoonoses; Socio economic burden

Indexed keywords

ANTITRYPANOSOMAL AGENT; NICLOSAMIDE; PRAZIQUANTEL;

AFRICAN TRYPANOSOMIASIS; ANTHRAX; ARTICLE; BOVINE TUBERCULOSIS; BRUCELLOSIS; CLONORCHIOSIS; CLONORCHIS SINENSIS; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; CYSTICERCOSIS; DECISION MAKING; DISABILITY; ECHINOCOCCOSIS; FASCIOLA; FASCIOLIASIS; HUMAN; INFECTION CONTROL; LEISHMANIASIS; LIVESTOCK; MORBIDITY; MORTALITY; NONHUMAN; OPISTHORCHIOSIS; OPISTHORCHIS VIVERRINI; PARAGONIMIASIS; PARAGONIMUS; PARASITOSIS; RABIES; SCHISTOSOMIASIS; SOCIETY; SOCIOECONOMICS; TAENIA SAGINATA; TAENIASIS; TOXOPLASMOSIS; TREMATODIASIS; ZOONOSIS; ANIMAL; COST OF ILLNESS; ECONOMICS; HEALTH; PARASITIC DISEASES; PARASITOLOGY; ZOONOSES;

ANIMALIA;

ANIMALS; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DECISION MAKING; GLOBAL HEALTH; HUMANS; LIVESTOCK; PARASITIC DISEASES; SOCIOECONOMIC FACTORS; ZOONOSES;

EID: 84880038948     PISSN: 03044017     EISSN: 18732550     Source Type: Journal    
DOI: 10.1016/j.vetpar.2013.04.004     Document Type: Article

References (88)

1. Alban L., Pozio E., Boes J., Boireau P., Boué F., Claes M., Cook A.J.C., Dorny P., Enemark H.L., Van der Giessen J., Hunt K.R., Howell M., Kirjusina M., Nöckler K., Rossi P., Smith G.C., Snow L., Taylor M.A., Theodoropoulos G., Vallée I., Viera-Pinto M.M., Zimmer I.A. Towards a standardised surveillance for Trichinella in the European Union. Prev. Vet. Med. 2011, 99:148-160.
2. Benner C., Carabin H., Sánchez-Serrano L.P., Budke C.M., Carmena D. Analysis of the economic impact of cystic echinococcosis in Spain. Bull. WHO 2010, 88:49-57.
3. Bhattarai R., Budke C.M., Carabin H., Proaño J.V., Flores-Rivera J., Corona T., Ivanek R., Snowden K.F., Flisser A. Estimating the non-monetary burden of neurocysticercosis in Mexico. PLoS Negl. Trop. Dis. 2012, 6:e1521.
4. Bruzinskaite R., Marcinkute A., Strupas K., Sokolovas V., Deplazes P., Mathis A., Eddi C., Sarkunas M. Alveolar echinococcosis, Lithuania. Emerg. Infect. Dis. 2007, 2007:1618-1619.
5. Budke C.M., Deplazes P., Torgerson P.R. Global socioeconomic impact of cystic echinococcosis. Emerg. Infect. Dis. 2006, 12:296-303.
6. Budke C.M., Jiamin Q., Qian W., Torgerson P.R. Economic effects of echinococcosis in a disease-endemic region of the Tibetan Plateau. Am. J. Trop. Med. Hyg. 2005, 73:2-10.
7. Budke C.M., Jiamin Q., Zinsstag J., Qian W., Torgerson P.R. Use of disability adjusted life years in the estimation of the disease burden of echinococcosis for a high endemic region of the Tibetan plateau. Am. J. Trop. Med. Hyg. 2004, 71:56-64.
8. Buxton D., Innes E. A commercial vaccine for ovine toxoplasmosis. Parasitology 1995, 110:S11-S16.
9. Carabin H., Budke C.M., Cowan L.D., Willingham A.L., Torgerson P.R. Methods for assessing the burden of parasitic zoonoses: echinococcosis and cysticercosis. Trends Parasitol. 2005, 21:327-333.
10. Carabin H., Krecek R.C., Cowan L.D., Michael L., Foyaca-Sibat H., Nash T., Willingham A.L. Estimation of the cost of Taenia solium cysticercosis in Eastern Cape Province, South Africa. Trop. Med. Int. Health 2006, 11:906-916.
11. Claridge J., Diggle P., McCann C.M., Mulcahy G., Flynn R., McNair J., Strain S., Welsh M., Baylis M., Williams D.J.L. Fasciola hepatica is associated with the failure to detect bovine tuberculosis in dairy cattle. Nat. Commun. 2012, 3:853.
12. Clausen J.H., Madsen H., Murrell K.D., Van P.T., Thu H.N.T., Do D.T., Thi L.A.N., Manh H.N., Dalsgaard A. Prevention and control of fish-borne zoonotic trematodes in fish nurseries. Vietnam Emerg. Infect. Dis. 2012, 18:1438-1445.
13. Copeman D.B., Copland R.S. Overcoming liver fluke as a constraint to ruminant production in South-East Asia. Importance and Potential Impact of Liver Fluke in Cattle and Buffalo 2008, 22-35. Australian Centre for International Agricultural Research (ACIAR), Canberra. G.D. Gray, R.S. Copland, D.B. Copeman (Eds.).
14. Craig P.S., Larrieu E. Control of cystic echinococcosis/hydatidosis: 1863-2002. Adv. Parasitol. 2006, 61:443-508.
15. Dalton J.P., Neill S.O., Stack C., Collins P., Walshe A., Sekiya M., Doyle S., Mulcahy G., Hoyle D., Khaznadji E., Moiré N., Brennan G., Mousley A., Kreshchenko N., Maule A.G., Donnelly S.M. Fasciola hepatica cathepsin L-like proteases: biology, function, and potential in the development of first generation liver fluke vaccines. Int. J. Parasitol. 2003, 33:1173-1181.
16. Davidson R.M. Control and eradication of animal diseases in New Zealand. N. Z. Vet. J. 2002, 50:6-12.
17. Davies P.R. Intensive swine production and pork safety. Foodborne Pathog. Dis. 2011, 8:189-201.
18. Deplazes P., Hegglin D., Gloor S., Romig T. Wilderness in the city: the urbanization of Echinococcus multilocularis. Trends Parasitol. 2003, 20:77-84.
19. Dorny P., Praet N. Taenia saginata in Europe. Vet. Parasitol. 2007, 149:22-24.
20. Dowdle W.R. The principles of disease elimination and eradication. Bull. WHO 1998, 76(Suppl. 2):22-25.
21. Dubey J.P. Toxoplasmosis in sheep - the last 20 years. Vet. Parasitol. 2009, 163:1-14.
22. Fasihi Harandi M., Budke C.M., Rostami S. The monetary burden of cystic echinococcosis in Iran. PLoS Negl. Trop. Dis. 2012, 6:e1915.
23. Fevre E.M., Von Wissmann B., Welburn S.C., Lutumba P. The burden of human African trypanosomiasis. PLoS Negl. Trop. Dis. 2008, 2:e333.
24. Fevre E.M., Odiit M., Coleman P.G., Woolhouse M.E.J., Welburn S.C. Estimating the burden of rhodesiense sleeping sickness during an outbreak in Serere, eastern Uganda. BMC Public Health 2008, 8:96.
25. Finkelstein J.L., Schleinitz M.D., Carabin H., McGarvey S.T. Decision-model estimation of the age-specific disability weight for schistosomiasis japonica: a systematic review of the literature. PLoS Negl. Trop. Dis. 2008, 2:e158.
26. Flisser A., Craig P.S., Ito A. Cysticercosis and taeniosis: Taenia solium, Taenia saginata and Taenia asiactica. Oxford Textbook of Zoonoses 2011, 625-642. Oxford University Press, Oxford, UK.
27. Freyre A., Bonino J., Falcón J., Castells D., Correa O., Casaretto A. The incidence and economic significance of ovine toxoplasmosis in Uruguay. Vet. Parasitol. 1997, 73:13-15.
28. Fürst T., Keiser J., Utzinger J. Global burden of human food-borne trematodiasis: a systematic review and meta-analysis. Lancet Infect. Dis. 2012, 12:210-221.
29. Fürst T., Duthaler U., Sripa B., Utzinger J., Keiser J. Trematode infections: liver and lung flukes. Infect. Dis. Clin. North Am. 2012, 26:399-419.
30. Gauci C.G., Jayashi C.M., Gonzalez A.E., Lackenby J., Lightowlers M.W. Protection of pigs against Taenia solium cysticercosis by immunization with novel recombinant antigens. Vaccine 2012, 30:3824-3828.
31. Geysen D., Kanobana K., Victor B., Rodriguez-Hidalgo R., De Borchgrave J., Brandt J., Dorny P. Validation of meat inspection results for Taenia saginata cysticercosis by PCR-restriction fragment length polymorphism. J. Food Prot. 2007, 70:236-240.
32. Gilbert R.E., Freeman K., Lago E.G., Bahia-Oliveira L.M.G., Tan H.K., Wallon M.W.B., Stanford M.R., Petersen E. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl. Trop. Dis. 2008, 2:e277.
33. Greikspoor A., Sondorp E., Vos T. Cost effectiveness analysis of humanitarian relief interventions: visceral leishmaniasis treatment in Sudan. Health Policy Plan. 1999, 14:70-76.
34. Havelaar A.H., Haagsma J.A., Mangen M.-J.J., Kemmeren J.M., Verhoef L.P.B., Vijgen S.M.C., Wilson M., Friesema I.H.M., Kortbeek L.M., Van Duynhoven Y.T.H.P., Van Pelt W. Disease burden of foodborne pathogens in the Netherlands, 2009. Int. J. Food Microbiol. 2012, 156:231-238.
35. Hegglin D., Deplazes P. Control strategy for Echinococcus multilocularis. Emerg. Infect. Dis. 2008, 14:1626-1628.
36. Hinz E. Trichinellosis and trichinellosis control in Germany. Southeast Asian J. Trop. Med. Public Health 1991, 22:S329-S333.
37. Hotez P.J., Fenwick A. Schistosomiasis in Africa: an emerging tragedy in our new global health decade. PLoS Negl. Trop. Dis. 2009, 3:e485.
38. Hunt McCauley E., Majid A.A., Tayeb A. Economic evaluation of the production impact of bovine schistosomiasis and vaccination in Sudan. Prev. Vet. Med. 1984, 2:735-754.
39. Jenkins D.J. Echinococcus granulosus in Australia, widespread and doing well!. Parasitol. Int. 2006, 55:S203-S206.
40. Jenkins H.E., Woodroffe R., Donnelly C.A. The duration of the effects of repeated widespread badger culling on cattle tuberculosis following the cessation of culling. PLoS ONE 2010, 5:e9090.
41. Jones J.L., Lopez A., Wilson M., Schulkin J., Gibbs R. Congenital toxoplasmosis: a review. Obstet. Gynecol. Surv. 2001, 56:296-305.
42. Kabasa J.D. Public-private partnership works to stamp out sleeping sickness in Uganda. Trends Parasitol. 2007, 23:191-192.
43. Kapel C.M.O. Changes in the EU legislation on Trichinella inspection - New challenges in the epidemiology. Vet. Parasitol. 2005, 132:189-194.
44. Kijlstra A., Jongert E. Toxoplasma-safe meat: close to reality?. Trends Parasitol. 2009, 25:18-22.
45. King C.H. Toward the elimination of schistosomiasis. N. Engl. J. Med. 2009, 360:106-109.
46. King C.H., Dangerfield-Cha M. The unacknowledged impact of chronic schistosomiasis. Chronic Illn. 2008, 4:65-79.
47. Kortbeek L.M., Hofhuis A., Nijhuis C.D.M., Havelaar A.H. Congenital toxoplasmosis and DALYs in the Netherlands. Mem. Inst. Oswaldo Cruz 2009, 104:370-373.
48. Koseoglu E., Yazar S., Koc I. Is Toxoplasma gondii a causal agent in migraine?. Am. J. Med. Sci. 2009, 338:120-122.
49. Lightowlers M.W. Cestode vaccines: origins, current status and future prospects. Parasitology 2006, 133(Suppl.):S27-S42.
50. Magona J.W., Walubengo J. Mass-treatment and insecticide-spraying of animal reservoirs for emergency control of Rhodesiense sleeping sickness in Uganda. J. Vector Borne Dis. 2011, 48:105-108.
51. Majorowski M.M., Carabin H., Kilani M., Bensalah A. Echinococcosis in Tunisia: a cost analysis. Trans. R. Soc. Trop. Med. Hyg. 2005, 99:268-278.
52. Mariner J.C., House J.A., Mebus C.A., Sollod A.E., Chibeu D., Jones B.A., Roeder P.L., Admassu B., van't Klooster G.G.M. Rinderpest eradication: appropriate technology and social innovations. Science 2012, 337:1309-1312.
53. McManus D.P., Gray D.J., Li Y., Feng Z., Williams G.M., Stewart D., Rey-Ladino J., Ross A.G. Schistosomiasis in the People's Republic of China: the era of the Three Gorges Dam. Clin Microbiol. Rev. 2010, 23:442-466.
54. Murray C.J. Rethinking DALYs. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk factors in 1990 and Projected to 2020 1996, Harvard School of Public Health, Cambridge, MA, pp. 1-98.
55. Murray C.J., Vos T., Lozano R., Naghavi M., Flaxman A.D., Michaud C., et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2197-2223.
56. Murrell K.D., Pozio E. Worldwide Occurrence and Impact of Human Trichinellosis 1986-2009. Emerg. Infect. Dis. 2011, 17:2194-2202.
57. Ndimubanzi P.C., Carabin H., Budke C.M., Nguyen H., Qian Y.-J., Rainwater E., Dickey M., Reynolds S., Stoner J.A. A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl. Trop. Dis. 2010, 4:e870.
58. Nahorski W.L., Knap J.P., Pawłowski Z.S., Krawczyk M., Polański J., Stefaniak J., Patkowski W., Szostakowska B., Pietkiewicz H., Grzeszczuk A., Felczak-Korzybska I., Gołab E., Wnukowska N., Paul M., Kacprzak E., Sokolewicz-Bobrowska E., Niścigorska-Olsen J., Czyrznikowska A., Chomicz L., Cielecka D., Myjak P. Human Alveolar Echinococcosis in Poland: 1990-2011. PLoS Negl. Trop. Dis. 2013, 7:e1986.
59. Palmer B.S. Meta-analysis of three case controlled studies and an ecological study into the link between cryptogenic epilepsy and chronic toxoplasmosis infection. Seizure 2007, 16:657-663.
60. Pappas G., Roussos N., Falagas M.E. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int. J. Parasitol. 2009, 39:1385-1394.
61. Piarroux M., Piarroux R., Giorgi R., Knapp J., Bardonnet K., Sudre B., Watelet J., Dumortier J., Gérard A., Beytout J., Abergel A., Mantion G., Vuitton D.A., Bresson-Hadni S. Clinical features and evolution of alveolar echinococcosis in France from 1982 to 2007: results of a survey in 387 patients. J. Hepatol. 2011, 55:1025-1033.
62. Pozio E. Trichinellosis in the European Union: epidemiology, ecology and economic impact. Parasitol. Today 1998, 14:35-38.
63. Praet N., Speybroeck N., Manzanedo R., Berkvens D., Nsame Nforninwe D., Zoli A., Quet F., Preux P.-M., Carabin H., Geerts S. The disease burden of Taenia solium cysticercosis in Cameroon. PLoS Negl. Trop. Dis. 2009, 3:e406.
64. Rapsch C., Schweizer G., Grimm F., Kohler L., Bauer C., Deplazes P., Braun U., Torgerson P.R. Estimating the true prevalence of Fasciola hepatica in cattle slaughtered in Switzerland in the absence of an absolute diagnostic test. Int. J. Parasitol. 2006, 36:1153-1158.
65. Roth F., Zinsstag J., Orkhon D., Chimed-Ochir G., Hutton G., Cosivi O., Carrin G., Otte J. Human health benefits from livestock vaccination for brucellosis: case study. Bull. WHO 2003, 81:867-876.
66. Schneider R., Aspöck H., Auer H. Unexpected increase of alveolar echincoccosis, Austria, 2011. Emerg. Infect. Dis. 2013, 19:475-477.
67. Schwabe C.W. Veterinary Medicine and Human Health 1984, Williams & Wilkins, Baltimore. 3rd ed.
68. Schwarzinger M., Stouthard M.E., Burström K., Nord E. Cross-national agreement on disability weights: the European Disability Weights Project. Popul. Health Metr. 2003, 1:9.
69. Schweiger A., Ammann R.W., Candinas D., Clavien P.-A., Eckert J., Gottstein B., Halkic N., Muellhaupt B., Prinz B.M., Reichen J., Tarr P.E., Torgerson P.R., Deplazes P. Human alveolar echinococcosis after fox population increase, Switzerland. Emerg. Infect. Dis. 2007, 13:878-882.
70. Schweizer G., Braun U., Deplazes P., Torgerson P.R. Estimating the financial losses due to bovine fasciolosis in Switzerland. Vet. Rec. 2005, 157:188-193.
71. Sripa B., Kaewkes S., Intapan P.M., Maleewong W., Brindley P.J. Food-borne trematodiases in Southeast Asia epidemiology, pathology, clinical manifestation and control. Adv. Parasitol. 2010, 72:305-350.
72. Torgerson P.R. Mathematical models for the control of cystic echinococcosis. Parasitol. Int. 2006, 55(Suppl.):S253-S258.
73. Torgerson P.R., Dowling P.M. Estimating the economic effects of cystic echinococcosis. Part 2. An endemic region in the United Kingdom, a wealthy, industrialized economy. Ann. Trop. Med. Parasitol. 2001, 95:177-185.
74. Torgerson P.R., Torgerson D.J. Public health and bovine tuberculosis: what's all the fuss about?. Trends Microbiol. 2010, 18:67-72.
75. Torgerson P.R., Macpherson C.N.L. The socioeconomic burden of parasitic zoonoses: global trends. Vet. Parasitol. 2011, 182:79-95.
76. Torgerson P.R., Carmona C., Bonifacino R. Estimating the economic effects of cystic echinococcosis: Uruguay, a developing country with upper-middle income. Ann. Trop. Med. Parasitol. 2000, 94:703-713.
77. Torgerson P.R., Dowling P.M., Abo-Shehada M.N. Estimating the economic effects of cystic echinococcosis. Part 3. Jordan, a developing country with lower-middle income. Ann. Trop. Med. Parasitol. 2001, 95:595-603.
78. Torgerson P.R., Schweiger A., Deplazes P., Pohar M., Reichen J., Ammann R.W., Tarr P.E., Halkik N., Müllhaupt B. Alveolar echinococcosis: from a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years. J. Hepatol. 2008, 49:72-77.
79. Torgerson P.R., Keller K., Magnotta M., Ragland N. The global burden of alveolar echinococcosis. PLoS Negl. Trop. Dis. 2010, 4:e722.
80. Torrey E.F., Bartko J.J., Yolken R.H. Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr. Bull. 2012, 38:642-647.
81. Usubalieva, J., Minbaeva, G., Ziadinov, I., Deplazes, P., Torgerson, P.R. The emergence of alveolar echinococcosis in Kyrgyzstan. Emerg. Infect. Dis., in press.
82. Van der Werf M.J., De Vlas S.J., Brooker S., Looman C.W.N., Nagelkerke N.J.D., Habbema J.D.F., Engels D. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop. 2003, 86:125-139.
83. Wang L.-D., Chen H.-G., Guo J.-G., Zeng X.-J., Hong X.-L., Xiong J.-J., Wu X.-H., Wang X.-H., Wang L.-Y., Xia G., Hao Y., Chin D.P., Zhou X.-N. A strategy to control transmission of Schistosoma japonicum in China. N. Engl. J. Med. 2009, 360:121-128.
84. Wang L., Utzinger J., Zhou X.-N. Schistosomiasis control: experiences and lessons from China. Lancet 2008, 372:1793-1795.
85. WHO, 2006. The Control of Neglected Zoonotic Diseases: A Route to Poverty Alleviation (No. WHO/SDE/FOS/2006.1). World Health Organisation, Geneva.
86. WHO The Control of Neglected Zoonotic Diseases: Community Based Interventions for Prevention and Control 2011, World Health Organisation, Geneva.
87. Woolhouse M.E.J., Gowtage-Sequeria S. Host range and emerging and reemerging pathogens. Emerg. Infect. Dis. 2005, 11:1842-1847.
88. Wu W., Qian X., Huang Y., Hong Q. A review of the control of clonorchiasis sinensis and Taenia solium taeniasis/cysticercosis in China. Parasitol. Res. 2012, 111:1879-1884.